News
- ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ICPT
11/26/2020 / 18:43 - GlobeNewswire
-
- RETA INVESTOR DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Reata Pharmaceuticals Inc.
11/26/2020 / 17:21 - GlobeNewswire
-
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
11/26/2020 / 06:30 - GlobeNewswire
-
- Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm – UROV, HDS, AKER, GV
11/26/2020 / 04:41 - GlobeNewswire
-
- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Reata Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – RETA
11/26/2020 / 04:28 - GlobeNewswire
-
- Pomerantz Law Firm Announces the Filing of a Class Action against Intercept Pharmaceuticals, Inc. and Certain Officers – ICPT
11/26/2020 / 04:15 - GlobeNewswire
-
- Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm
11/26/2020 / 02:26 - GlobeNewswire
-
- BioNTech and InstaDeep Announce Strategic Collaboration and Form AI Innovation Lab to Develop Novel Immunotherapies
11/25/2020 / 13:45 - GlobeNewswire
-
- RETA: Zhang Investor Law Alerts Investors to Deadline in Securities Class Action Lawsuit Against Reata Pharmaceuticals, Inc. – RETA
11/24/2020 / 18:00 - GlobeNewswire
-
- CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements for Glioblastoma Multiforme (GBM) Therapy
11/24/2020 / 14:00 - GlobeNewswire
Real-time